Results 41 to 50 of about 937 (121)

Advances in the management of gout: From current strategies to emerging therapies. [PDF]

J Int Med Res
Zhao Q, Dai X.
europepmc   +1 more source

Response to Allopurinol and Febuxostat According to the Fractional Excretion of Urate in Men With Gout. [PDF]

Arthritis Care Res (Hoboken)
Richette P, Walter-Petrich A, Nguyen QD, Resche-Rigon M, Nguyen QHD, Do MD, Mai TP, Nguyen TD, Perez-Ruiz F, Letavernier E, Pascart T, Latourte A, Ea HK, Bardin T.   +13 more
europepmc   +1 more source

A treat-to-target urate management strategy does not improve kidney outcome in patients with chronic kidney disease and asymptomatic hyperuricemia: a target trial emulation. [PDF]

Ann Med
Liu Q, Hu Y, He R, Fang Z, He W, Zheng D, Jin J, He Q.   +7 more
europepmc   +1 more source

Cost-Effectiveness of Low-Dose Colchicine Prophylaxis When Starting Allopurinol Using the "Start-Low Go-Slow" Approach for Gout: Evidence From a Noninferiority Randomized Double-Blind Placebo-Controlled Trial. [PDF]

Arthritis Care Res (Hoboken)
Pryymachenko Y, Wilson R, Dalbeth N, Abbott JH, Stamp L.   +4 more
europepmc   +1 more source

Assessing willingness to pay for HLA-B*58:01 genetic testing before allopurinol initiation and its potential impact on future health policy, Thailand. [PDF]

Sci Rep
Towiwat P, Bamrungsawad N, Buttham B, Nakham A, Upakdee N.   +4 more
europepmc   +1 more source

Acute cardiovascular events after discontinuation of xanthine oxidase inhibitors: a cohort study. [PDF]

Clin Rheumatol
Magagnoli J, Cummings TH, Ambati M, Sutton SS, Ambati J.   +4 more
europepmc   +1 more source

Gout-Related Medication Use After Initiating Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Gout and Type 2 Diabetes: Population-Based Target Trial Emulation Studies. [PDF]

Diabetes Care
McCormick N, Burrack N, Yokose C, Lu N, Wexler DJ, Rai SK, Challener GJ, Aviña-Zubieta JA, McCoy RG, Abuhasira R, Choi HK.   +10 more
europepmc   +1 more source

Guideline adherence of xanthine oxidase inhibitor utilization to treat gout in primary care. [PDF]

J Manag Care Spec Pharm
Claus LW, Auten ME, Saseen JJ, Billups SJ.   +3 more
europepmc   +1 more source

Perceptions About Asymptomatic Hyperuricemia and Views About Urate-Lowering Therapy in People With Asymptomatic Hyperuricemia. [PDF]

Arthritis Care Res (Hoboken)
Dalbeth N, Stewart S, Gamble GD, Mihov B, Stamp LK, Haslett J, Taylor WJ, Merriman TR, Tabi-Amponsah AD, Horne A, Neogi T, Pascart T, Andrés M, Peral-Garrido ML, Norkuviene E, Vazquez-Mellado J, Uhlig T, Sun M, Li C, Petrie KJ.   +19 more
europepmc   +1 more source

Gout on the acute medical take. [PDF]

Clin Med (Lond)
Abhishek A, Cipolletta E.
europepmc   +1 more source